Vericel's heart drug successful in mid-stage study
0
(Reuters) - Vericel Corp said its experimental drug reduced death, hospitalizations and emergency visits in patients, who are at risk of a heart failure, in a mid-stage study, sending its shares up 80 percent in premarket trading.